BASSANI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.063
NA - Nord America 871
EU - Europa 665
AF - Africa 242
SA - Sud America 209
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 759
SG - Singapore 363
CN - Cina 221
IT - Italia 166
BR - Brasile 138
HK - Hong Kong 136
VN - Vietnam 53
DE - Germania 50
RU - Federazione Russa 50
NL - Olanda 46
PL - Polonia 40
KR - Corea 39
FI - Finlandia 36
CI - Costa d'Avorio 29
FR - Francia 27
IN - India 25
GB - Regno Unito 20
SE - Svezia 18
AR - Argentina 17
ES - Italia 17
JP - Giappone 17
CH - Svizzera 16
MX - Messico 14
TH - Thailandia 13
ID - Indonesia 12
PK - Pakistan 12
ZA - Sudafrica 12
CA - Canada 11
CZ - Repubblica Ceca 11
EC - Ecuador 11
MA - Marocco 11
TW - Taiwan 11
AL - Albania 10
AT - Austria 10
CG - Congo 10
PS - Palestinian Territory 10
PT - Portogallo 10
BA - Bosnia-Erzegovina 9
CY - Cipro 9
HU - Ungheria 9
IE - Irlanda 9
ML - Mali 9
PY - Paraguay 9
SK - Slovacchia (Repubblica Slovacca) 9
AU - Australia 8
AZ - Azerbaigian 8
BJ - Benin 8
EG - Egitto 8
HT - Haiti 8
JO - Giordania 8
LB - Libano 8
MU - Mauritius 8
MY - Malesia 8
PH - Filippine 8
TN - Tunisia 8
TR - Turchia 8
TZ - Tanzania 8
VE - Venezuela 8
AD - Andorra 7
AM - Armenia 7
AO - Angola 7
BD - Bangladesh 7
BG - Bulgaria 7
BO - Bolivia 7
GA - Gabon 7
HN - Honduras 7
KZ - Kazakistan 7
NO - Norvegia 7
AE - Emirati Arabi Uniti 6
BB - Barbados 6
BF - Burkina Faso 6
BS - Bahamas 6
BW - Botswana 6
BZ - Belize 6
CL - Cile 6
DK - Danimarca 6
ET - Etiopia 6
GH - Ghana 6
GP - Guadalupe 6
GR - Grecia 6
IQ - Iraq 6
IR - Iran 6
IS - Islanda 6
JM - Giamaica 6
KE - Kenya 6
LC - Santa Lucia 6
MK - Macedonia 6
MZ - Mozambico 6
PA - Panama 6
RO - Romania 6
RS - Serbia 6
TJ - Tagikistan 6
UA - Ucraina 6
UY - Uruguay 6
BE - Belgio 5
CM - Camerun 5
EE - Estonia 5
GN - Guinea 5
IL - Israele 5
MD - Moldavia 5
Totale 2.882
Salva come PNG Salva come JPEG
Città #
Singapore 195
Hong Kong 128
Ashburn 114
Santa Clara 87
Beijing 71
Hefei 53
Chandler 39
Padova 38
Los Angeles 33
Bytom 31
Abidjan 29
Seoul 29
Boardman 27
Columbus 27
Chicago 24
Helsinki 22
Fairfield 19
Ogden 17
Hanoi 15
Ho Chi Minh City 15
Padua 15
Munich 14
Buffalo 11
New York 11
São Paulo 11
Houston 10
Milan 9
Phoenix 9
Amman 8
Baku 8
Bamako 8
Barcelona 8
Brazzaville 8
Cotonou 8
Andorra la Vella 7
Bangkok 7
Brooklyn 7
Dar es Salaam 7
Dublin 7
Lappeenranta 7
Libreville 7
Rio de Janeiro 7
Rome 7
Seattle 7
Warsaw 7
Atlanta 6
Belgrade 6
Brasília 6
Cambridge 6
Castries 6
Council Bluffs 6
Dallas 6
Denver 6
Johannesburg 6
Luanda 6
Maputo 6
Montevideo 6
Montreal 6
Stockholm 6
Vienna 6
Wilmington 6
Amsterdam 5
Asunción 5
Basel 5
Bridgetown 5
Camerino 5
Casablanca 5
Cochabamba 5
Conakry 5
Dushanbe 5
Elk Grove Village 5
Harare 5
Les Abymes 5
London 5
Medford 5
Melbourne 5
Nairobi 5
Panama City 5
Prague 5
Princeton 5
Tokyo 5
Woodbridge 5
Accra 4
Antananarivo 4
Athens 4
Bishkek 4
Cagliari 4
Cairo 4
Cape Town 4
Douala 4
Fort Liberté 4
Frankfurt am Main 4
Gaborone 4
Guayaquil 4
Jakarta 4
Kampala 4
Kazan' 4
Kigali 4
Lisbon 4
Lusaka 4
Totale 1.501
Salva come PNG Salva come JPEG
Nome #
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation 206
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 155
Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus 144
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions 137
Application, evaluation, and improvement of computational methodologies in drug discovery 136
Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations 136
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 136
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma 130
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 127
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants 125
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? 124
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro 123
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 122
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? 120
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 112
In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment 112
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? 106
Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study 103
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking {GPCR} Antagonists? 103
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 100
Investigating RNA-protein recognition mechanisms through supervised molecular dynamics (SuMD) simulations 97
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? 96
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma 94
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies 92
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 91
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system 81
Totale 3.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.407
article - articoli 11.046
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 0 0 0 19 7 39 2 3 15
2022/2023154 13 0 1 8 19 16 2 32 22 17 21 3
2023/2024320 12 27 53 24 39 22 48 24 30 9 13 19
2024/2025996 16 47 48 36 113 42 55 107 108 51 151 222
2025/20261.553 238 266 486 492 71 0 0 0 0 0 0 0
Totale 3.108